A Cochrane Systematic Review that set out to assess the effectiveness and tolerability of subdermal implantable contraceptives compared to other reversible methods of contraception found that they ...
Clinical data support a 5-year duration for the Nexplanon implant, with no reported pregnancies during the extended 2-year study period. The Food and Drug Administration (FDA) has extended the ...
(RTTNews) - Organon (OGN) announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for NEXPLANON (etonogestrel implant). NEXPLANON is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results